GO Therapeutics
Business Services · Massachusetts, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
22 Strathmore Rd, Natick, Massachusetts,...Phone Number
(800) 978-6543Website
www.gotherapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About GO Therapeutics
GO Therapeutics specializes in developing advanced cancer therapies by identifying super-clean targets that are exclusively found on tumor cells. Their innovative discovery platform aims to provide novel targets and antibodies necessary for the next generation of solid tumor treatments. The company addresses the limitations of current therapeutic modalities, such as T-cell bispecific antibodies and CAR-T, by focusing on clean cancer targets. Their intended clients include healthcare providers and researchers in the oncology field seeking effective treatment options for solid tumors.Explore more
GO Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is GO Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if GO Therapeutics is spiking on competitors!
Check if GO Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Congratulate Masked Content for being promoted to Masked Content at GO Therapeutics
Funding: Get notified immidiatlly once GO Therapeutics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
GO Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when GO Therapeutics launches new products
Click to see if GO Therapeutics had a recent Job posting/layoffs
Earning: See what the market has to say on GO Therapeutics recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined GO Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to GO Therapeutics
Compare insights from companies similar to GO Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
GO Therapeutics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
GO Therapeutics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about GO Therapeutics.
GO Therapeutics Tech Stack
A closer look at the technologies used by GO Therapeutics
GO Therapeutics News & Media
Astellas and GO Therapeutics Enter into Strategic Research and License Agreement to Develop Novel Antibodies for Immuno-Oncology
- Collaboration to Accelerate Next-Generation Cancer Treatment - TOKYO and CAMBRIDGE, Mass., June 1, 2022 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") and GO Therapeutics, Inc. (Co-Founder and CEO: Constantine Theodoropulos, "GO")...GO Therapeutics Enters into a License Agreement with Roche for New Glycotargeting Bispecific Cancer Treatment
CAMBRIDGE, Mass.--(BUSINESS WIRE)--#Roche--GO Therapeutics, Roche sign licensing agreement worth up to $195 million for new glycotargeting bispecific cancer treatment
Read more news
Top Business Services Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding GO Therapeutics
Sign Up For FreeTo access detailed company insights
GO Therapeutics specializes in developing advanced cancer therapies by identifying super-clean targets that are exclusively found on tumor cells. Their innovative discovery platform aims to provide novel targets and antibodies necessary for the next generation of solid tumor treatments. The company addresses the limitations of current therapeutic m... Read More
